BioMed Central | Members | BC Cancer Agency

Submit a manuscript Register Contact us

Institution search

Search by institution name/city

Members

Australia (21)
Austria (6)
Belgium (2)
Brazil (4)
Burkina Faso (1)
Canada (27)
Central African Republic (1)
China (3)
Cyprus (3)
Czech Republic (1)
Denmark (1)
Ethiopia (1)
Finland (6)
France (6)
Germany (48)
Ghana (3)
Greece (1)
Hong Kong (2)
Hungary (1)
India (7)
Ireland (1)
Israel (1)
Italy (13)
Japan (1)
Kenya (2)
Korea, South (1)
Lebanon (1)
Lithuania (1)
Luxembourg (1)
Madagascar (1)
Malaysia (3)
Mexico (1)
Morocco (2)
Netherlands (10)
New Zealand (1)
Nigeria (2)
Norway (3)
Poland (1)
Portugal (1)
Romania (1)
South Africa (6)
Spain (14)
Sweden (9)
Switzerland (10)
Taiwan (3)
Tanzania (2)
Thailand (1)
Trinidad and Tobago (1)
Uganda (1)
United Kingdom (41)
United States of America (153)

Advertisement

Supporter Member - BC Cancer Agency

Research staff and students at BC Cancer Agency:

Do you realize that you will get a 15% discount on the article-processing charges of all research articles accepted for publication in journals published by BioMed Central, Chemistry Central and SpringerOpen? Read more information about publishing your articles with us.

Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at BC Cancer Agency

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	1.	Research Time series analysis of fine particulate matter and asthma reliever dispensations in populations affected by forest fires Catherine T Elliott, Sarah B Henderson, Victoria Wan Environmental Health 2013, 12:11 (28 January 2013) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Dr C. Elliott and colleagues monitor the impact of chronic lung diseases by measuring dispensation of Salubutamol in forest fire afflicted regions in British Columbia.
	2.	Research Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras Irene Karam, Sarah Hamilton, Alan Nichol, Ryan Woods, Caroline Speers, Hagen Kennecke, Scott Tyldesley Radiation Oncology 2013, 8:12 (9 January 2013) Abstract \| Full text \| PDF \| PubMed
	3.	Review Engaging people who use drugs in policy and program development: A review of the literature Lianping Ti, Despina Tzemis, Jane A Buxton Substance Abuse Treatment, Prevention, and Policy 2012, 7:47 (24 November 2012) Abstract \| Full text \| PDF \| PubMed
	4.	Research article Trends in postpartum hemorrhage from 2000 to 2009: a population-based study Azar Mehrabadi, Jennifer A Hutcheon, Lily Lee, Robert M Liston, KS Joseph BMC Pregnancy and Childbirth 2012, 12:108 (11 October 2012) Abstract \| Full text \| PDF \| PubMed
	5.	Research Relationships between family physicians’ referral for palliative radiotherapy, knowledge of indications for radiotherapy, and prior training: a survey of rural and urban family physicians Robert A Olson, Sonca Lengoc, Scott Tyldesley, John French, Colleen McGahan, Jenny Soo Radiation Oncology 2012, 7:73 (18 May 2012) Abstract \| Full text \| PDF \| PubMed
	6.	Research Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes Katy Milne, Cheryl Alexander, John R Webb, Winnie Sun, Kristy Dillon, Steve E Kalloger, C Blake Gilks, Blaise Clarke, Martin Köbel, Brad H Nelson Journal of Translational Medicine 2012, 10:33 (27 February 2012) Abstract \| Full text \| PDF \| PubMed
	7.	Research article Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer Nathan R West, Katy Milne, Pauline T Truong, Nicol Macpherson, Brad H Nelson, Peter H Watson Breast Cancer Research 2011, 13:R126 (8 December 2011) Abstract \| Full text \| PDF \| PubMed
	8.	Research article The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity Wieslawa H Dragowska, Sherry A Weppler, Mohammed A Qadir, Ling Wong, Yannick Franssen, Jennifer HE Baker, Anita I Kapanen, Guido JJ Kierkels, Dana Masin, Andrew I Minchinton, Karen A Gelmon, Marcel B Bally BMC Cancer 2011, 11:420 (1 October 2011) Abstract \| Full text \| PDF \| PubMed
	9.	Research Understanding the impact of 1q21.1 copy number variant Chansonette Harvard, Emma Strong, Eloi Mercier, Rita Colnaghi, Diana Alcantara, Eva Chow, Sally Martell, Christine Tyson, Monica Hrynchak, Barbara McGillivray, Sara Hamilton, Sandra Marles, Aziz Mhanni, Angelika J Dawson, Paul Pavlidis, Ying Qiao, Jeanette J Holden, Suzanne ME Lewis, Mark O'Driscoll, Evica Rajcan-Separovic Orphanet Journal of Rare Diseases 2011, 6:54 (8 August 2011) Abstract \| Full text \| PDF \| PubMed
	10.	Review The functional role of long non-coding RNA in human carcinomas Ewan A Gibb, Carolyn J Brown, Wan L Lam Molecular Cancer 2011, 10:38 (13 April 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	11.	Short Report Efficient assembly of very short oligonucleotides using T4 DNA Ligase Daniel R Horspool, Robin JN Coope, Robert A Holt BMC Research Notes 2010, 3:291 (9 November 2010) Abstract \| Full text \| PDF \| PubMed
	12.	Research article *LNCaP Atlas: Gene expression associated with in vivo* progression to castration-recurrent prostate cancer** Tammy L Romanuik, Gang Wang, Olena Morozova, Allen Delaney, Marco A Marra, Marianne D Sadar BMC Medical Genomics 2010, 3:43 (24 September 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13.	Research article A sequence-based approach to identify reference genes for gene expression analysis Raj Chari, Kim M Lonergan, Larissa A Pikor, Bradley P Coe, Chang Zhu, Timothy HW Chan, Calum E MacAulay, Ming-Sound Tsao, Stephen Lam, Raymond T Ng, Wan L Lam BMC Medical Genomics 2010, 3:32 (3 August 2010) Abstract \| Full text \| PDF \| PubMed
	14.	Research article An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer Raj Chari, Bradley P Coe, Emily A Vucic, William W Lockwood, Wan L Lam BMC Systems Biology 2010, 4:67 (17 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	15.	Research Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B_5b(CYB5B) Derek Murphy, Jeremy Parker, Minglong Zhou, Faisal M Fadlelmola, Christian Steidl, Aly Karsan, Randy D Gascoyne, Hong Chen, Diponkar Banerjee Molecular Cancer 2010, 9:14 (26 January 2010) Abstract \| Full text \| PDF \| PubMed
	16.	Methodology Evolutionary concepts in biobanking - the BC BioLibrary Peter H Watson, Janet E Wilson-McManus, Rebecca O Barnes, Sara C Giesz, Adrian Png, Richard G Hegele, Jacquelyn N Brinkman, Ian R Mackenzie, David G Huntsman, Anne Junker, Blake Gilks, Erik Skarsgard, Michael Burgess, Samuel Aparicio, Bruce M McManus Journal of Translational Medicine 2009, 7:95 (12 November 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17.	Research article *Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ* hybridization (FISH): pathologist assessment compared to quantitative image analysis** Gulisa Turashvili, Samuel Leung, Dmitry Turbin, Kelli Montgomery, Blake Gilks, Rob West, Melinda Carrier, David Huntsman, Samuel Aparicio BMC Cancer 2009, 9:165 (29 May 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	18.	Research Identification of transcripts with enriched expression in the developing and adult pancreas Brad G Hoffman, Bogard Zavaglia, Joy Witzsche, Teresa Ruiz de Algara, Mike Beach, Pamela A Hoodless, Steven JM Jones, Marco A Marra, Cheryl D Helgason Genome Biology 2008, 9:R99 (14 June 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary The expression profile of different developmental stages of the murine pancreas and predictions of transcription factor interactions, provides a framework for pancreas regulatory networks and development.
	19.	Research article Jab1 is a target of EGFR signaling in ERα-negative breast cancer Jiaxu Wang, Rebecca O Barnes, Nathan R West, Melanie Olson, Jenny E Chu, Peter H Watson Breast Cancer Research 2008, 10:R51 (6 June 2008) Abstract \| Full text \| PDF \| PubMed
	20.	Research article Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities Joshua Z Press, Alessandro De Luca, Niki Boyd, Sean Young, Armelle Troussard, Yolanda Ridge, Pardeep Kaurah, Steve E Kalloger, Katherine A Blood, Margaret Smith, Paul T Spellman, Yuker Wang, Dianne M Miller, Doug Horsman, Malek Faham, C Blake Gilks, Joe Gray, David G Huntsman BMC Cancer 2008, 8:17 (22 January 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| F1000 Medicine \| F1000 Biology \| Editor’s summary High grade serous ovarian carcinomas can be subclassified into three distinct groups based on genetic and epigenetic alterations of BRCA1, with distinct molecular alterations involving the PI3K/AKT and p53 pathways.
	21.	Research article Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study Simon J Crabb, Chris D Bajdik, Samuel Leung, Caroline H Speers, Hagen Kennecke, David G Huntsman, Karen A Gelmon Breast Cancer Research 2008, 10:R6 (14 January 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	22.	Research Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines Faisal M Fadlelmola, Minglong Zhou, Ronald J de Leeuw, Nirpjit S Dosanjh, Karynn Harmer, David Huntsman, Wan L Lam, Diponkar Banerjee Molecular Cancer 2008, 7:2 (7 January 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	23.	Research article *Correlations of EGFR* mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients** Trevor J Pugh, Gwyn Bebb, Lorena Barclay, Margaret Sutcliffe, John Fee, Chris Salski, Robert O'Connor, Cheryl Ho, Nevin Murray, Barbara Melosky, John English, Jeurgen Vielkind, Doug Horsman, Janessa J Laskin, Marco A Marra BMC Cancer 2007, 7:128 (13 July 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	24.	Research article Relationship between insertion/deletion (indel) frequency of proteins and essentiality Simon K Chan, Michael Hsing, Fereydoun Hormozdiari, Artem Cherkasov BMC Bioinformatics 2007, 8:227 (28 June 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	25.	Research article *Time to decide about risk-reducing mastectomy: A case series of BRCA1/2* gene mutation carriers** Mary McCullum, Joan L Bottorff, Mary Kelly, Stephanie A Kieffer, Lynda G Balneaves BMC Women's Health 2007, 7:3 (6 March 2007) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Women with BRCA1/2 gene mutation need time, information and long term support to help them decide whether to undergo a risk reducing mastectomy.